Soo Ki Kim Selected Research

Soo Ki Kim Research Topics

Disease

10	Hepatocellular Carcinoma (Hepatoma) 07/2023 - 01/2011
6	Infections 12/2022 - 01/2013
6	Neoplasms (Cancer) 01/2020 - 01/2011
5	Fibrosis (Cirrhosis) 12/2022 - 05/2014
5	Chronic Hepatitis C 03/2021 - 01/2013
4	Chronic Hepatitis B 01/2024 - 01/2015
3	Carcinogenesis 01/2024 - 03/2014
3	Hepatitis B 10/2023 - 01/2015
3	Liver Diseases (Liver Disease) 12/2022 - 01/2015
2	Sarcoidosis (Schaumann Disease) 01/2023 - 01/2017
2	Hepatitis C 01/2019 - 01/2017
2	Inflammation (Inflammations) 03/2017 - 03/2014
1	Hypotension (Low Blood Pressure) 11/2023
1	Chronic Renal Insufficiency 11/2023
1	COVID-19 01/2023
1	Hyperalgesia 06/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Ulcerative Colitis 01/2020
1	Thrombosis (Thrombus) 05/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Necrosis 06/2017
1	Dyspnea (Shortness of Breath) 01/2017
1	Carcinoma (Carcinomatosis) 09/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2016
1	Rhabdomyolysis 12/2015
1	Liver Failure 12/2015
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 05/2014

Drug/Important Bio-Agent (IBA)

7	InterferonsIBA 12/2022 - 01/2013
5	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 01/2013
4	Antiviral Agents (Antivirals)IBA 10/2023 - 01/2019
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2024 - 01/2011
3	SofosbuvirIBA 03/2021 - 01/2016
3	Cytidine DeaminaseIBA 03/2017 - 01/2013
2	Surface Antigens (Surface Antigen)IBA 01/2024 - 03/2023
2	NucleosidesIBA 01/2024 - 03/2023
2	nasIBA 10/2023 - 12/2022
2	DNA (Deoxyribonucleic Acid)IBA 03/2023 - 01/2015
2	Messenger RNA (mRNA)IBA 01/2023 - 06/2017
2	entecavir FDA Link 12/2022 - 01/2015
2	Tenofovir (Viread)FDA Link 12/2022 - 01/2015
2	Lamivudine (Epivir)FDA Link 12/2015 - 01/2015
2	Tumor Biomarkers (Tumor Markers)IBA 10/2015 - 01/2011
2	NucleotidesIBA 03/2014 - 01/2013
1	HDL LipoproteinsIBA 11/2023
1	Lipoproteins (Lipoprotein)IBA 11/2023
1	Transaminases (Aminotransferases)IBA 10/2023
1	Bevacizumab (Avastin)FDA Link 07/2023
1	atezolizumabIBA 07/2023
1	tenofovir alafenamideIBA 03/2023
1	BNT162 VaccineIBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 06/2022
1	Sorafenib (BAY 43-9006)FDA Link 06/2022
1	lenvatinibIBA 06/2022
1	ledipasvirIBA 03/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Vitamin E FDA LinkGeneric 01/2019
1	VaccinesIBA 03/2017
1	Hyaluronic Acid (Hyaluronan)IBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Bone Morphogenetic Protein 7IBA 01/2017
1	Connective Tissue Growth FactorIBA 01/2017
1	Cyclin-Dependent Kinase Inhibitor p16IBA 09/2016
1	adefovirIBA 12/2015
1	GadoliniumIBA 10/2015
1	Pentetic Acid (DTPA)FDA LinkGeneric 10/2015
1	gadolinium ethoxybenzyl DTPA FDA Link 10/2015
1	SimeprevirIBA 01/2015
1	daclatasvirIBA 01/2015
1	telaprevirIBA 01/2015
1	Hepatitis B e AntigensIBA 01/2015
1	asunaprevirIBA 01/2015
1	C-Reactive ProteinIBA 05/2014
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 05/2014
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 05/2014
1	Organic Anion TransportersIBA 05/2014
1	Fatty Acid-Binding ProteinsIBA 05/2014
1	CateninsIBA 05/2014
1	GlypicansIBA 05/2014
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 05/2014
1	EnzymesIBA 01/2013
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2012
1	Hematoxylin (Haematoxylon)IBA 01/2012

Therapy/Procedure

13	Therapeutics 01/2024 - 01/2013
1	Secondary Prevention 10/2023
1	Molecular Targeted Therapy 06/2022
1	Aftercare (After-Treatment) 01/2017
1	Oral Administration 01/2015